These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 22175134

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Challenging the pyramid. A new look at therapeutic approaches for rheumatoid arthritis. Earlier intervention with second line therapies.
    Ward JR.
    J Rheumatol Suppl; 1990 Nov; 25():18-23. PubMed ID: 1980313
    [Abstract] [Full Text] [Related]

  • 4. DMARDs in the treatment of rheumatoid arthritis: current agents and future developments.
    Simon LS.
    Int J Clin Pract; 2000 May; 54(4):243-9. PubMed ID: 10912314
    [Abstract] [Full Text] [Related]

  • 5. [Gold preparations in therapy of rheumatoid and psoriatic arthritis].
    Nasonova VA, Lukina GV, Sigidin IaA, Badokin VV.
    Ter Arkh; 2003 May; 75(5):88-90. PubMed ID: 12847908
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy of additive DMARD therapy in patients with rheumatoid arthritis. Double blind controlled trial using bucillamine and placebo with maintenance doses of gold sodium thiomalate.
    Yasuda M, Sakai K, Oribe M, Yoshioka K, Takahashi H, Ohtsuka E, Wada T, Shiokawa S, Yamamoto M, Ichibangase Y.
    J Rheumatol; 1994 Jan; 21(1):44-50. PubMed ID: 8151586
    [Abstract] [Full Text] [Related]

  • 7. One-year experience in patients treated with auranofin following completion of a parallel, controlled trial comparing auranofin, gold sodium thiomalate, and placebo.
    Williams HJ, Dahl SL, Ward JR, Karg M, Willkens RF, Meenan RF, Altz-Smith M, Clegg DO, Mikkelsen WM, Kay DR.
    Arthritis Rheum; 1988 Jan; 31(1):9-14. PubMed ID: 3125841
    [Abstract] [Full Text] [Related]

  • 8. Rheumatoid arthritis therapy: the slow-acting agents.
    Hardin JG.
    Hosp Pract (Off Ed); 1989 Jun 15; 24(6):163-8, 170, 173-8. PubMed ID: 2566617
    [No Abstract] [Full Text] [Related]

  • 9. [Comparative study of the effects of auranofin and aurothiomalate on laboratory and clinical indicators in patients with rheumatoid arthritis].
    Vlak T, Stambuk B.
    Reumatizam; 1998 Jun 15; 46(1):7-19. PubMed ID: 9921004
    [Abstract] [Full Text] [Related]

  • 10. A long-term five-year randomized controlled trial of hydroxychloroquine, sodium aurothiomalate, auranofin and penicillamine in the treatment of patients with rheumatoid arthritis.
    Jessop JD, O'Sullivan MM, Lewis PA, Williams LA, Camilleri JP, Plant MJ, Coles EC.
    Br J Rheumatol; 1998 Sep 15; 37(9):992-1002. PubMed ID: 9783766
    [Abstract] [Full Text] [Related]

  • 11. A three year comparative multicenter study of auranofin (AF) and gold sodium thiomalate (GST) in the treatment of rheumatoid arthritis (RA).
    Rau R, Schattenkirchner M, Müller-Fassbender H, Kaik B, Zeidler H.
    Clin Rheumatol; 1987 Sep 15; 6 Suppl 2():43-52. PubMed ID: 3121238
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. Subsets of responses.
    Ward JR, Williams HJ, Boyce E, Egger MJ, Reading JC, Samuelson CO.
    Am J Med; 1983 Dec 30; 75(6A):133-7. PubMed ID: 6419595
    [Abstract] [Full Text] [Related]

  • 13. A multicentre double-blind comparison of auranofin, intramuscular gold thiomalate and placebo in patients with psoriatic arthritis.
    Palit J, Hill J, Capell HA, Carey J, Daunt SO, Cawley MI, Bird HA, Nuki G.
    Br J Rheumatol; 1990 Aug 30; 29(4):280-3. PubMed ID: 2116206
    [Abstract] [Full Text] [Related]

  • 14. Differential influences of gold sodium thiomalate and bucillamine on the generation of CD14+ monocyte-lineage cells from bone marrow of rheumatoid arthritis patients.
    Hirohata S, Yanagida T, Hashimoto H, Tomita T, Ochi T, Nakamura H, Yoshino S.
    Clin Immunol Immunopathol; 1997 Sep 30; 84(3):290-5. PubMed ID: 9281388
    [Abstract] [Full Text] [Related]

  • 15. [Phagocytic activity in rheumatoid arthritis].
    Jelcić A, Car A, Gnjidić Z, Sabioncello A.
    Reumatizam; 1992 Sep 30; 39(2):17-9. PubMed ID: 1366147
    [Abstract] [Full Text] [Related]

  • 16. [Comparative evaluation of the effectiveness of gold preparations and D-penicillamine and their tolerance in rheumatoid arthritis. I. The effect on the indicators of their activity and tolerance].
    Slobodina GA, Kanevskaia MZ, Krel' AA, Chichasova NV.
    Revmatologiia (Mosk); 1989 Sep 30; (1):8-16. PubMed ID: 2501852
    [Abstract] [Full Text] [Related]

  • 17. [Gold compounds and D-penicillamine for therapy of rheumatoid arthritis].
    Miyamoto S, Inoue T.
    Nihon Rinsho; 1992 Mar 30; 50(3):515-20. PubMed ID: 1588740
    [Abstract] [Full Text] [Related]

  • 18. Oral gold in rheumatoid arthritis.
    Drug Ther Bull; 1988 Sep 05; 26(18):69-72. PubMed ID: 3139386
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of psoriatic arthritis with auranofin and gold sodium thiomalate.
    Brückle W, Dexel T, Grasedyck K, Schattenkirchner M.
    Clin Rheumatol; 1994 Jun 05; 13(2):209-16. PubMed ID: 8088061
    [Abstract] [Full Text] [Related]

  • 20. [Well controlled comparative study in early rheumatoid arthritis with gold sodium thiomalate vs. auranofin].
    Yamamoto S, Mitomo N, Saito T, Nishioka K, Inoue K, Uchida S, Ohata N, Murasawa A, Suzuki A, Mitsui T.
    Ryumachi; 1990 Feb 05; 30(1):26-44. PubMed ID: 2116042
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.